Clinical Trials Directory

Trials / Completed

CompletedNCT00241657

Immune Responses to BCG Vaccination in Malawi and the UK

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
Sponsor
London School of Hygiene and Tropical Medicine · Academic / Other
Sex
All
Age
12 Years – 25 Years
Healthy volunteers
Accepted

Summary

BCG vaccination has been found to provide greater protection against TB in the UK than in Malawi. This study compares immune responses in BCG-vaccinated and unvaccinated teenagers and young adults in Malawi and in the UK.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBCG

Timeline

First posted
2005-10-19
Last updated
2005-12-15

Locations

2 sites across 2 countries: Malawi, United Kingdom

Source: ClinicalTrials.gov record NCT00241657. Inclusion in this directory is not an endorsement.